UroGen Pharma Ltd (URGN) — Tangible Net Worth Ratio
UroGen Pharma Ltd (URGN) has a Tangible Net Worth Ratio of 100.0% as of September 2024. This metric is calculated by deducting intangible assets ($0.00) from net assets ($25.52 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See URGN total equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
UroGen Pharma Ltd Tangible Net Worth Ratio (2013–2021)
This chart shows how UroGen Pharma Ltd's Tangible Net Worth Ratio has changed across 9 annual periods from 2013 to 2021. As of September 2024, the ratio stands at 100.0%, reflecting net assets of $25.52 Million with intangible assets of $0.00 USD. Also explore URGN net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for UroGen Pharma Ltd (2013–2021)
The table below presents the year-by-year Tangible Net Worth Ratio for UroGen Pharma Ltd from 2013 to 2021, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see URGN market cap overview.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2021 | 100.0% | $8.41 Million | $0.00 | $119.75 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $96.36 Million | $0.00 | $122.00 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $180.30 Million | $0.00 | $202.39 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $90.09 Million | $0.00 | $103.56 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $68.52 Million | $0.00 | $75.55 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $16.31 Million | $0.00 | $23.06 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $17.15 Million | $0.00 | $19.39 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $3.47 Million | $0.00 | $4.36 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $2.74 Million | $0.00 | $3.23 Million | — |